Chesapeake Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2
Closed -$1 420
2023
Q3
$1 Hold
2
﹤0.01% 443
2023
Q2
$441 Buy
+2
New +$227 ﹤0.01% 387

Other funds holding MRK

Chesapeake Asset Management's MRK Position: Q1 2026 in Review

Chesapeake Asset Management reduced its Merck (MRK) stake by 6.9% in Q1 2026, selling an estimated $128K and leaving 15,053 shares worth $1.81M. The position accounts for 1.44% of the portfolio, ranked #14.

Chesapeake Asset Management first reported a position in MRK in Q2 2013 and has held it in 40 quarters since. The position peaked at $5M in Q3 2014. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Chesapeake Asset Management held 15,053 shares of Merck worth $1.81M as of Q1 2026.
  • Chesapeake Asset Management sold 1,113 Merck shares in Q1 2026, an estimated $128K.
  • Merck made up 1.44% of Chesapeake Asset Management's portfolio in Q1 2026, its #14 holding.
  • Chesapeake Asset Management first reported a position in Merck in Q2 2013 and has held it in 40 quarters since.
  • Chesapeake Asset Management's Merck position peaked at $5M in Q3 2014.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Chesapeake Asset Management's 13F filing for Q1 2026, filed 12 May 2026.